SCHEMBL26572467

SCHEMBL26572467

Cc1ccc(-c2ccc(F)cc2Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.46
ACHE P22303 1/20 0.46
GRM2 Q14416 1/20 0.43
GCGR P47871 2/20 0.43
MAPK14 Q16539 2/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
PTGS2 P35354 2/20 0.42
FASN P49327 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 2/20 0.41
NISCH Q9Y2I1 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
ALOX15 P16050 1/20 0.40
MAOB P27338 1/20 0.39
TP53 P04637 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39
PRKAB2 O43741 1/20 0.39
PRKAG1 P54619 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31067069 0.87 GRM2 (0.48) HSD11B1GRM2GCGRMAPK14PTGS2
SCHEMBL1262207 0.87 GRM2 (0.48) HSD11B1GRM2GCGRMAPK14PTGS2
SCHEMBL31066929 0.85 GRM2 (0.47) HSD11B1GRM2GCGRMAPK14PTGS2
SCHEMBL12999476 0.84 ABL1 (0.47) HSD11B1ACHEGCGRMAPK14MEN1
SCHEMBL19323001 0.83 HPGD (0.45) ACHEMEN1KMT2AKDM4ENPC1
SCHEMBL24196502 0.80 GRM2 (0.43) HSD11B1GRM2GCGRMAPK14PTGS2
SCHEMBL22452543 0.80 TAAR1 (0.47) HSD11B1GRM2GCGRMAPK14PTGS2
SCHEMBL11693196 0.80 ESR1 (0.52) GRM2MEN1KMT2AFASNSMN1; SMN2
SCHEMBL11694239 0.79 GSK3B (0.48) GCGRMAPK14MEN1KMT2ASMN1; SMN2
SCHEMBL15060599 0.79 GRM2 (0.50) HSD11B1GRM2GCGRMAPK14MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183405-A2 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2023-09-28 WO disclosed